QuantRx Biomedical Corporation
QTXB
$0.0005
$0.0003150.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.06% | -5.00% | -16.53% | -28.55% | -47.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.06% | -5.00% | -16.53% | -28.55% | -47.66% |
| Operating Income | 3.06% | 5.00% | 16.53% | 28.55% | 47.66% |
| Income Before Tax | 0.80% | 0.94% | 3.22% | -2.85% | 47.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.80% | 0.94% | 3.22% | -2.85% | 47.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 0.80% | 0.94% | 3.22% | -2.85% | 47.66% |
| EBIT | 3.06% | 5.00% | 16.53% | 28.55% | 47.66% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00% | 0.00% | 0.00% | -3.13% | 48.44% |
| Normalized Basic EPS | 0.00% | 0.00% | 0.00% | 4.55% | 12.50% |
| EPS Diluted | 0.00% | 0.00% | 0.00% | -3.13% | 48.44% |
| Normalized Diluted EPS | 0.00% | 0.00% | 0.00% | 4.55% | 12.50% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
